Since Galectin-1-glycan lattice formation is sensitive to α2,6 sialylation [51], ST6GAL1 transfer to tumor-associated immune cells may outcompete the PD-1/PDL1 axis to foster immunosuppressive TME. This evidence concerns the gene ST6GAL1 and neoplasm.